UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 10 | October 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 7
July-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2407657


Registration ID:
545651

Page Number

g494-g502

Share This Article


Jetir RMS

Title

Development And Validation of Novel HPTLC Method for The Estimation of Pimobendan In Tablet Dosage Form

Abstract

A novel, accurate, exact, sensitive and appropriate High Performance Thin Layer Chromatography (HPTLC) method was developed and validated for the determination and estimation of Pimobendan in pharmaceutical tablet dosage form. The chromatographic separation for Pimobendan was achieved on Silica gel 60 F254 HPTLC plate as the stationary phase using a standardized mobile phase composed of n-Hexane: Ethyl acetate: Ethanol: Glacial acetic acid (GAA) in the following ratio of 70:15:15:1%v/v/v/v. Identification and quantification of Pimobendan were done at 330nm. The system was found to produced sharp peak and well resolved discrete band at an appropriate Rf value i.e. 0.442. The performance of proposed method was validated with respect to linearity, recovery, precision, robustness, LOD and LOQ in accordance with ICH guidelines. The linearity for molecule was found between the range of 4-40ng/band with correlation coefficient 0.9991. The LOD (limit of detection) and LOQ (limit of quantification) were found to be 1.04 ng/band and 3.16 ng/band respectively. The current method is novel since there is no reported HPTLC method for the estimation of Pimobendan in pharmaceutical tablet dosage form and method can be used successfully for quality checks and routine analysis of Pimobendan.

Key Words

Pimobendan, High Performance Thin Layer Chromatography, CAMAG Linomat 5, LOD, LOQ

Cite This Article

"Development And Validation of Novel HPTLC Method for The Estimation of Pimobendan In Tablet Dosage Form", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 7, page no.g494-g502, July-2024, Available :http://www.jetir.org/papers/JETIR2407657.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Development And Validation of Novel HPTLC Method for The Estimation of Pimobendan In Tablet Dosage Form", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 7, page no. ppg494-g502, July-2024, Available at : http://www.jetir.org/papers/JETIR2407657.pdf

Publication Details

Published Paper ID: JETIR2407657
Registration ID: 545651
Published In: Volume 11 | Issue 7 | Year July-2024
DOI (Digital Object Identifier):
Page No: g494-g502
Country: Mumbai, Maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000233

Print This Page

Current Call For Paper

Jetir RMS